Fair value · NOVONIX Ltd (NVX) · updated 2026-09-13 · from 20-F FY2025
NOVONIX trades at $2.96. We are not reading assumptions out of that price: our price is for one ADS, which represents 4 ordinary shares, but this company files its per-share figures per ordinary share — so these methods need a per-share restatement we do not yet publish.
Everything below is unaffected: the filed statements, the filing they came from, and NVX’s growth history are all as reported.
The filing behind these numbers
NOVONIX Ltd- Revenue
- $5.6M
- Diluted EPS
- $-0.14
- Free cash flow
- $-102.4M
- operating cash flow − capital expenditure
- Diluted shares
- 681.7M
- weighted average
20-F FY2025 · fiscal year ended 2025-12-31 · filed 2026-02-26 · accession 0001193125-26-072814
Open this filing on sec.govNeed NVX data in your own agent or pipeline?
The valuation data behind this page — DCF fair value, margin of safety, PE vs industry, analyst estimates — is also available programmatically through the EvidInvest MCP server & financial data API for Claude, Cursor, or any MCP client and HTTP pipeline.